BD Green

457 total citations
15 papers, 386 citations indexed

About

BD Green is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, BD Green has authored 15 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in BD Green's work include Diabetes Treatment and Management (14 papers), Peptidase Inhibition and Analysis (11 papers) and Neuropeptides and Animal Physiology (9 papers). BD Green is often cited by papers focused on Diabetes Treatment and Management (14 papers), Peptidase Inhibition and Analysis (11 papers) and Neuropeptides and Animal Physiology (9 papers). BD Green collaborates with scholars based in United Kingdom, United States and Bangladesh. BD Green's co-authors include Peter R. Flatt, Finbarr O’Harte, Victor A. Gault, Patrick Harriott, Nigel Irwin, MH Mooney, Brett Greer, Clifford J. Bailey, Mark Mooney and Jane T. McCluskey and has published in prestigious journals such as Diabetologia, Archives of Biochemistry and Biophysics and Metabolism.

In The Last Decade

BD Green

15 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
BD Green United Kingdom 11 298 171 166 160 105 15 386
MH Mooney United Kingdom 11 323 1.1× 144 0.8× 176 1.1× 138 0.9× 124 1.2× 13 412
M Bersani Italy 8 253 0.8× 217 1.3× 131 0.8× 154 1.0× 44 0.4× 19 437
Kerstin Kühn‐Wache Canada 9 199 0.7× 88 0.5× 121 0.7× 161 1.0× 131 1.2× 12 358
Shinpei Fujimoto Japan 2 311 1.0× 249 1.5× 100 0.6× 161 1.0× 51 0.5× 2 424
J Szecówka Sweden 15 238 0.8× 239 1.4× 256 1.5× 238 1.5× 36 0.3× 19 520
Suad Efendic Sweden 9 99 0.3× 120 0.7× 105 0.6× 213 1.3× 16 0.2× 11 364
Monique Lambert Belgium 11 54 0.2× 123 0.7× 176 1.1× 211 1.3× 54 0.5× 24 366
J. P. Raufman United States 8 56 0.2× 106 0.6× 183 1.1× 200 1.3× 32 0.3× 11 336
Lars Dan Johansen Denmark 8 99 0.3× 69 0.4× 126 0.8× 245 1.5× 34 0.3× 8 416
Emilia E. Savage Australia 9 245 0.8× 127 0.7× 229 1.4× 360 2.3× 13 0.1× 9 451

Countries citing papers authored by BD Green

Since Specialization
Citations

This map shows the geographic impact of BD Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BD Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BD Green more than expected).

Fields of papers citing papers by BD Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BD Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BD Green. The network helps show where BD Green may publish in the future.

Co-authorship network of co-authors of BD Green

This figure shows the co-authorship network connecting the top 25 collaborators of BD Green. A scholar is included among the top collaborators of BD Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BD Green. BD Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
McKillop, Aine, BD Green, Nigel Irwin, et al.. (2007). Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation. Diabetologia. 50. 1 indexed citations
2.
McKillop, Aine, et al.. (2006). Insulinotropic actions of nateglinide are accompanied by inhibition of dipeptidyl peptidase-IV activity. Diabetologia. 49. 482–483. 3 indexed citations
3.
4.
5.
Green, BD, Nigel Irwin, Victor A. Gault, et al.. (2005). Chronic treatment with exendin(9–39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice. Journal of Endocrinology. 185(2). 307–317. 24 indexed citations
6.
Green, BD, Victor A. Gault, MH Mooney, et al.. (2004). Molecular, cellular and biological characteristics of DPP IV-resistant acetylated analogues of GLP-1.. Diabetic Medicine. 21. 26–26. 1 indexed citations
7.
Green, BD, MH Mooney, Victor A. Gault, et al.. (2004). N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology. 180(3). 379–388. 50 indexed citations
8.
9.
Green, BD, et al.. (2004). Function of a long‐term, GLP‐1‐treated, insulin‐secreting cell line is improved by preventing DPP IV‐mediated degradation of GLP‐1. Diabetes Obesity and Metabolism. 7(5). 563–569. 16 indexed citations
10.
Green, BD, Victor A. Gault, Finbarr O’Harte, & Peter R. Flatt. (2004). A comparison of the cellular and biological properties of DPP‐IV‐resistant N‐glucitol analogues of glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide. Diabetes Obesity and Metabolism. 7(5). 595–604. 11 indexed citations
11.
Green, BD, Victor A. Gault, Peter R. Flatt, et al.. (2004). Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid. Archives of Biochemistry and Biophysics. 428(2). 136–143. 39 indexed citations
12.
Irwin, Nigel, Victor A. Gault, BD Green, et al.. (2004). Long-acting Tyr(1)-modified analogues of GIP with significantly improved antihyperglycaemic and insulinotropic properties. Research Portal (Queen's University Belfast). 47. 1 indexed citations
13.
Green, BD, Victor A. Gault, Nigel Irwin, et al.. (2003). Metabolic Stability, Receptor Binding, cAMP Generation, Insulin Secretion and Antihyperglycaemic Activity of Novel N-Terminal Glu9-Substituted Analogues of Glucagon-Like Peptide-1. Biological Chemistry. 384(12). 1543–51. 23 indexed citations
14.
Green, BD, Victor A. Gault, MH Mooney, et al.. (2003). Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. Journal of Molecular Endocrinology. 31(3). 529–540. 34 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MH Mooney Breakdown of academic impact, for papers by M Bersani Breakdown of academic impact, for papers by Kerstin Kühn‐Wache Breakdown of academic impact, for papers by Shinpei Fujimoto Breakdown of academic impact, for papers by J Szecówka Breakdown of academic impact, for papers by Suad Efendic Breakdown of academic impact, for papers by Monique Lambert Breakdown of academic impact, for papers by J. P. Raufman Breakdown of academic impact, for papers by Lars Dan Johansen Breakdown of academic impact, for papers by Emilia E. Savage
Rankless by CCL
2026